UniProt ID | GCYB1_HUMAN | |
---|---|---|
UniProt AC | Q02153 | |
Protein Name | Guanylate cyclase soluble subunit beta-1 {ECO:0000305} | |
Gene Name | GUCY1B1 {ECO:0000312|HGNC:HGNC:4687} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 619 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Mediates responses to nitric oxide (NO) by catalyzing the biosynthesis of the signaling molecule cGMP.. | |
Protein Sequence | MYGFVNHALELLVIRNYGPEVWEDIKKEAQLDEEGQFLVRIIYDDSKTYDLVAAASKVLNLNAGEILQMFGKMFFVFCQESGYDTILRVLGSNVREFLQNLDALHDHLATIYPGMRAPSFRCTDAEKGKGLILHYYSEREGLQDIVIGIIKTVAQQIHGTEIDMKVIQQRNEECDHTQFLIEEKESKEEDFYEDLDRFEENGTQESRISPYTFCKAFPFHIIFDRDLVVTQCGNAIYRVLPQLQPGNCSLLSVFSLVRPHIDISFHGILSHINTVFVLRSKEGLLDVEKLECEDELTGTEISCLRLKGQMIYLPEADSILFLCSPSVMNLDDLTRRGLYLSDIPLHDATRDLVLLGEQFREEYKLTQELEILTDRLQLTLRALEDEKKKTDTLLYSVLPPSVANELRHKRPVPAKRYDNVTILFSGIVGFNAFCSKHASGEGAMKIVNLLNDLYTRFDTLTDSRKNPFVYKVETVGDKYMTVSGLPEPCIHHARSICHLALDMMEIAGQVQVDGESVQITIGIHTGEVVTGVIGQRMPRYCLFGNTVNLTSRTETTGEKGKINVSEYTYRCLMSPENSDPQFHLEHRGPVSMKGKKEPMQVWFLSRKNTGTEETKQDDD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
26 | Ubiquitination | PEVWEDIKKEAQLDE HHHHHHHHHHHCCCC | 57.81 | - | |
145 | Ubiquitination | EREGLQDIVIGIIKT CCCCCHHHHHHHHHH | 1.24 | - | |
165 | Ubiquitination | HGTEIDMKVIQQRNE HCCCCCHHHHHHHHH | 32.22 | - | |
192 | Phosphorylation | ESKEEDFYEDLDRFE HHCCCCHHHCHHHHH | 22.36 | 28796482 | |
395 | Phosphorylation | KKTDTLLYSVLPPSV HCCCEEEECCCCHHH | 10.39 | 27067055 | |
396 | Phosphorylation | KTDTLLYSVLPPSVA CCCEEEECCCCHHHH | 19.69 | 27067055 | |
401 | Phosphorylation | LYSVLPPSVANELRH EECCCCHHHHHHHHC | 31.74 | 27067055 | |
471 | Ubiquitination | RKNPFVYKVETVGDK CCCCCEEEEEEECCC | 28.44 | - | |
540 | Phosphorylation | IGQRMPRYCLFGNTV CCCCCCEEEEECCEE | 6.40 | - | |
541 | Ubiquitination | GQRMPRYCLFGNTVN CCCCCEEEEECCEEE | 2.40 | - | |
561 | Ubiquitination | ETTGEKGKINVSEYT EECCCCCEEEEHHEE | 42.02 | - | |
567 | Phosphorylation | GKINVSEYTYRCLMS CEEEEHHEEEEEECC | 11.10 | - | |
574 | Phosphorylation | YTYRCLMSPENSDPQ EEEEEECCCCCCCCC | 19.00 | 29978859 | |
578 | Phosphorylation | CLMSPENSDPQFHLE EECCCCCCCCCCCCC | 49.35 | 29978859 | |
591 | Phosphorylation | LEHRGPVSMKGKKEP CCCCCCCCCCCCCCC | 20.22 | 29978859 | |
609 | Phosphorylation | WFLSRKNTGTEETKQ EEEEECCCCCCCCCC | 48.82 | 28152594 | |
611 | Phosphorylation | LSRKNTGTEETKQDD EEECCCCCCCCCCCC | 28.71 | 28152594 | |
614 | Phosphorylation | KNTGTEETKQDDD-- CCCCCCCCCCCCC-- | 27.98 | 28152594 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
192 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GCYB1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GCYB1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NOS3_HUMAN | NOS3 | physical | 12676772 | |
HS90A_HUMAN | HSP90AA1 | physical | 12676772 | |
A4_HUMAN | APP | physical | 21832049 | |
GCYA2_HUMAN | GUCY1A2 | physical | 28514442 | |
GCYA3_HUMAN | GUCY1A3 | physical | 28514442 | |
MXRA7_HUMAN | MXRA7 | physical | 28514442 | |
UACA_HUMAN | UACA | physical | 28514442 | |
MTFR2_HUMAN | MTFR2 | physical | 28514442 | |
MYCB2_HUMAN | MYCBP2 | physical | 28514442 | |
BBS2_HUMAN | BBS2 | physical | 28514442 | |
MUL1_HUMAN | MUL1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...